A recent study demonstrated that in the ALS-FUS mutation mouse model, EIF1AX and several other translation initiation factors were downregulated, which led to an impairment in protein translation, mitochondrial dysfunctions, synaptic plasticity impairment, reduced spine density, and cognitive deficits 41. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.